Health Condition 1: B999- Unspecified infectious disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with fever (axillary temperature of more than 100 F) admitted to pediatric ward in Ruby Hall Clinic and willing to participate in study.
Exclusion criteria
Exclusion criteria: 1.Those patients who have received either of the drug in previous 6 hours. 2.Received antibiotics prior to admission. 3.Those receiving anti-coagulants warfarin, heparin etc. 4.Those patients having localized inflammatory pain. 5.Known case of asthma. 6.Known case of allergy to either drug. 7.Chronic cardiac or hepatic or renal failure requiring ICU care. 8.Any clinical adverse event or serious illness. 9.Those patients not willing to participate in study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. time taken to reduce fever by either of the drug 2. The decrease in fever associated discomfort following administration of either drug.Timepoint: AT BASELINE, 4 DAYS AND 8 DAYS | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine any immediate adverse effects following drug administration.Timepoint: 24 hours | — |
Countries
India
Contacts
RUBY HALL CLINIC